Hans‐Jörg Roth - Concepedia

Author

Hans‐Jörg Roth

Novartis (Switzerland)

Also Known As

Hans-Jörg Roth, Hans‐Jorg Roth, Hans‐JÖRg Roth, Hans‐Jörg Roth, Roth, Hans-Jörg

Publications

775

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)ETH Zurich Novartis Institutes for BioMedical Research Analytisches Laboratorium

About

Hans‐Jörg Roth is an author at Novartis (Switzerland) specializing in biochemistry, natural sciences, and biomolecular engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	7	7	426
2	Natural Sciences	5	5	356
3	Medicine	3	3	99
4	Engineering	2	2	120
5	Biomedical Engineering	1	1	70

Hans‐Jörg Roth

Publications

638

Citations

H-Index

Page 1

	Year	Citations
Warum pentose‐und nicht hexose‐nucleinsäuren? Teil III. Oligo(2′,3′‐dideoxy‐β‐<scp>D</scp>‐glucopyranosyl) nucleotide (‘homo‐DNS’): Paarungesigenschaften Jürg Hunziker, Hans‐Jörg Roth, Markus Böhringer, Helvetica Chimica Acta Nucleic Acid ChemistryBioorganic ChemistryBiochemistryNatural SciencesNucleic Acid Biochemistry	1993	138
Warum Pentose‐ und nicht Hexose‐Nucleinsäuren??. Teil II. Oligonucleotide aus 2′,3′‐Dideoxy‐β‐<scp>D</scp>‐glucopyranosyl‐Bausteinen (‘Homo‐DNS’): Herstellung. Markus Böhringer, Hans‐Jörg Roth, Jürg Hunziker, Helvetica Chimica Acta BiosynthesisBioorganic ChemistryNicht Hexose‐nucleinsäurenBiochemistryAutomated Dna Synthesis	1992	95
Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides Jagna Witek, Shuzhe Wang, Benjamin Schroeder, Journal of Chemical Information and Modeling	2018	71
Design and Development of a Cyclic Decapeptide Scaffold with Suitable Properties for Bioavailability and Oral Exposure Marianne Fouché, Michael Schäfer, Jörg Berghausen, ChemMedChem Tissue EngineeringOral BioavailabilityEngineeringSuitable PropertiesPeptide Engineering	2016	70
Warum Pentose‐ und nicht Hexose‐Nucleinsäuren??. Teil VI. ‘Homo‐DNS’: <sup>1</sup>H‐, <sup>13</sup>C‐, <sup>31</sup>P‐ und <sup>15</sup>N‐NMR‐spektroskopische Untersuchung von ddGlc(A‐A‐A‐A‐A‐T‐T‐T‐T‐T) in wässriger Lösung Gottfried Otting, Martin Billeter, Kurt Wüthrich, Helvetica Chimica Acta	1993	57
Lessons for Oral Bioavailability: How Conformationally Flexible Cyclic Peptides Enter and Cross Lipid Membranes Stephanie M. Linker, Christian Schellhaas, Anna S. Kamenik, Journal of Medicinal Chemistry Membrane StructureProteinlipid InteractionOral BioavailabilityEngineeringBiochemistry	2023	50
Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides Shuzhe Wang, Gerhard König, Hans‐Jörg Roth, Journal of Medicinal Chemistry	2021	48
Quality Control in Combinatorial Chemistry: Determinations of Amounts and Comparison of the “Purity” of LC−MS-Purified Samples by NMR, LC−UV and CLND Elodie Letot, Guido Koch, Rocco Falchetto, Journal of Combinatorial Chemistry	2005	36
Pharmacokinetic Studies around the Mono‐ and Difunctionalization of a Bioavailable Cyclic Decapeptide Scaffold Marianne Fouché, Michael Schäfer, Markus Blatter, ChemMedChem Pharmacokinetic StudiesGeneric ScaffoldMedicinal ChemistryPharmaceutical ScienceBiochemistry	2016	29
Synthesis and Properties of 2′‐Deoxy‐1′,2′‐seco‐D‐ribosyl (5′ → 3′)oligonucleotides (= 1′,2′‐seco‐DNA) containing adenine and thymine Ling Peng, Hans‐Jörg Roth Helvetica Chimica Acta Dna NanotechnologySolid PhaseBioorganic ChemistryNucleic Acid ChemistryBiochemistry	1997	24

Page 1